Incomplete inhibition of phosphorylation of 4E-BP1 as a mechanism of primary resistance to ATP-competitive mTOR inhibitors
Gregory S. Ducker(University of Utah), Robert S. Warren(University of California, San Francisco), Byron Hann(University of California, San Francisco), Emily K. Bergsland(University of California, San Francisco), Eric K. Nakakura(University of California, San Francisco), David B. Donner(Baker Heart and Diabetes Institute), Cyril H. Benes(Harvard University), Jeff Settleman(Discovery Centre), Chloé E. Atreya(The University of Texas MD Anderson Cancer Center), Jeff Simko(University of California, San Francisco), Kevan M. Shokat(Howard Hughes Medical Institute), Yun K. Hom(UCSF Helen Diller Family Comprehensive Cancer Center), Mary Matli(University of California, San Francisco)
Cited by 92
Related Papers
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
|Nature|2013|2.5k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
|Nature|2010|1.8k
IRE1 Signaling Affects Cell Fate During the Unfolded Protein Response
|Science|2007|1.4k